Chat GPT, a relatively unknown therapy for HFpEF, and two fun studies on statins and secondary prevention are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I. Artificial Intelligence and CHAT GPT
Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet
https://www.medscape.com/viewarticle/990381
- Potential and Pitfalls of ChatGPT and Natural-Language Artificial Intelligence Models for Diabetes Education
https://doi.org/10.2337/dc23-0197
II. Exercise and HFpEF
AHA, ACC Advocate Supervised Exercise Training in HFpEF
https://www.medscape.com/viewarticle/990351
- Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology
https://doi.org/10.1016/j.jacc.2023.02.012
III. Statins and Muscles
Statins Don't Worsen Muscle Injury From Moderately Intense Exercise
https://www.medscape.com/viewarticle/990473
- Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users https://doi.org/10.1016/j.jacc.2023.01.043
IV. Statins in Secondary Prevention
Treat to LDL Target or High-Intensity Statin for All With Clinical CAD: LODESTAR
https://www.medscape.com/viewarticle/989884
- Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease
https://jamanetwork.com/journals/jama/article-abstract/2802214
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact: news@medscape.net
